NEW YORK (GenomeWeb) — Response Genetics has been warned by Nasdaq that it is not in compliance with a rule to remain listing on the Nasdaq Capital Market, the company recently disclosed in a document filed with the US Securities and Exchange Commission.

Nasdaq sent a letter to the firm in late November saying it does not meet a listing requirement calling for a minimum of $2.5 million stockholders' equity. For the third quarter ended Sept. 30, Response Genetics had shareholders' equity of about $2.0 million, according to the firm's Form 10-Q. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.